Successful control of nosocomial transmission of the USA300 clone of community-acquired meticillin-resistant Staphylococcus aureus in a UK paediatric burns centre

Journal of Hospital Infection

Volumn 84, Issue 4, 2013, Pages 319-322

  Patel, M ^a   Thomas, H C ^a   Room, J ^a   Wilson, Y ^a   Kearns, A ^b   Gray, J ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Community acquired MRSA; Paediatric burns; PVL; USA300

Indexed keywords

CLINDAMYCIN; PSEUDOMONIC ACID;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; CLINICAL ARTICLE; COMMUNICABLE DISEASE; EPIDEMIC; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR CLONING; NONHUMAN; SKIN INFECTION; SURVIVAL; TOPICAL TREATMENT; UNITED KINGDOM;

COMMUNITY-ACQUIRED MRSA; PAEDIATRIC BURNS; PVL; USA300;

ADULT; BURN UNITS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; ENVIRONMENTAL MICROBIOLOGY; FEMALE; GREAT BRITAIN; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFECTION CONTROL; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS;

EID: 84880629305     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.04.013     Document Type: Article

References (10)

1. Otter J.A., French G.L. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. JHosp Infect 2011, 79:189-193.
2. Brown D.F.J., Edwards D.I., Hawkey P.M., et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). JAntimicrob Chemother 2005, 56:1000-1018.
3. Coia J.E., Duckworth G.J., Edwards D.I., et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. JHosp Infect 2006, 63(Suppl. 1):S1-S44.
4. Guidance in the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England 2008, 1-51. PVL Sub Group Steering Group on Healthcare Associated Infection, Health Protection Agency, London. 2nd ed.
5. Al-Rawahi G.N., Reynolds S., Porter S.D. Community-associated CMRSA-10 (USA-300) is the predominant strain among methicillin-resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian tertiary care hospital. JEmerg Med 2010, 38:6-11.
6. Bassetti M., Nicco E., Mikulska M. Why is community-associated MRSA spreading across the world and how will it change clinical practice?. Int J Antimicrob Agents 2009, 34(Suppl. 1):S15-S19.
7. Larsen A.R., Böcher S., Stegger M., Goering R., Pallesen L.V., Skov R. Epidemiology of European community-associated methicillin-resistant Staphylococcus aureus clonal complex 80 type IV strains isolated in Denmark from 1993 to 2004. JClin Microbiol 2008, 46:62-68.
8. Chua K., Laurent F., Coombs G., Grayson M.L., Howden B.P. Antimicrobial resistance: not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis 2011, 52:99-114.
9. Witte W. Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?. Clin Microbiol Infect 2009, 15(Suppl. 7):17-25.
10. Desai R., Pannaraj P.S., Agopian J., Sugar C.A., Liu G.Y., Miller L.G. Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites. Am J Infect Control 2011, 39:219-225.